Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PRPO
stocks logo

PRPO

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2024Q2
5.90M
+67%
--
--
Estimates Revision
Stock Price
Go Up
up Image
+38.73%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Precipio Inc (PRPO.O) is 1.50, compared to its 5-year average forward P/E of 0.71. For a more detailed relative valuation and DCF analysis to assess Precipio Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.71
Current PE
1.50
Overvalued PE
9.80
Undervalued PE
-8.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.51
Current PS
0.00
Overvalued PS
3.11
Undervalued PS
-0.09
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

PRPO News & Events

Events Timeline

(ET)
2025-12-04
08:10:00
Precipio Reports Data Access Incident, No Impact on Operations
select
2025-09-02 (ET)
2025-09-02
10:01:49
Precipio Ends At-the-Market Agreement with Alliance Global
select
2024-10-08 (ET)
2024-10-08
10:04:57
Precipio expands Bloodhound MPN panel by adding CALR mutation subtyping
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
12-04Globenewswire
Precipio Reports Limited Unauthorized Data Access, No Operational Impact
  • Incident Overview: Precipio recently identified unauthorized access to a specific data folder within its secure cloud environment, but the incident was limited to the file storage server and did not impact the company's operations, diagnostics processes, or customer services.
  • Response Measures: The company immediately initiated its incident response procedures and engaged an external cybersecurity law firm and forensic specialists to assist in the investigation, ensuring system security while resetting passwords company-wide and enhancing monitoring, with no evidence of continued unauthorized access currently found.
  • Data Security: Initial investigations indicate that the unauthorized third party accessed and downloaded files primarily containing historical operational procedures, temperature logs, and vendor invoices, which pose no risk or damage to the company, and did not include any patient Social Security numbers or financial information.
  • Financial Impact: Precipio maintains a comprehensive cybersecurity insurance policy and expects that costs associated with the investigation and response efforts will be covered according to policy terms, with no anticipated material impact on operations, customers, patient care, or shareholders as a result of this incident.
[object Object]
Preview
1.0
11-05Newsfilter
Precipio Schedules Shareholder Update Call for Q3 2025

  • Corporate Update Call: Precipio, Inc. will host its Q3-2025 corporate update call on November 17, 2025, at 5:00 PM ET, providing updates on its core businesses and allowing for pre-submitted questions from listeners.

  • Company Overview: Precipio is a healthcare biotechnology company focused on improving cancer diagnostics to reduce misdiagnoses, enhance laboratory workflow, and improve patient outcomes through innovative diagnostic products and services.

  • Information Access: Investors and the public can access more information about Precipio through its website and social media platforms, where the company shares disclosures, presentations, and other material information.

  • Forward-Looking Statements: The press release includes forward-looking statements regarding the company's future performance, which are subject to risks and uncertainties, and should not be relied upon as guarantees of future results.

[object Object]
Preview
6.5
09-23NASDAQ.COM
Zacks Analyst Blog Features HSBC, American Express, TotalEnergies, Armanino Foods of Distinction, and Precipio

  • Zacks Analyst Blog Highlights: The Zacks Equity Research team featured stocks including HSBC Holdings, American Express, TotalEnergies, Armanino Foods, and Precipio, providing insights into their performance and market strategies.

  • HSBC Performance and Challenges: HSBC's shares have outperformed the foreign banking industry, but restructuring efforts and subdued loan demand may temporarily impact revenue growth despite a strong capital position.

  • American Express Growth Factors: American Express has seen revenue growth driven by new products and travel spending, but rising expenses and loan loss provisions pose risks to its profitability.

  • Micro-Cap Stocks Insights: Armanino Foods and Precipio have shown significant year-to-date gains, with Armanino focusing on cost control and expansion, while Precipio is experiencing strong revenue growth but faces liquidity challenges.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Precipio Inc (PRPO) stock price today?

The current price of PRPO is 24.61 USD — it has decreased -3.11 % in the last trading day.

arrow icon

What is Precipio Inc (PRPO)'s business?

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

arrow icon

What is the price predicton of PRPO Stock?

Wall Street analysts forecast PRPO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRPO is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Precipio Inc (PRPO)'s revenue for the last quarter?

Precipio Inc revenue for the last quarter amounts to 6.77M USD, increased 29.91 % YoY.

arrow icon

What is Precipio Inc (PRPO)'s earnings per share (EPS) for the last quarter?

Precipio Inc. EPS for the last quarter amounts to -0.05 USD, decreased -88.10 % YoY.

arrow icon

What changes have occurred in the market's expectations for Precipio Inc (PRPO)'s fundamentals?

The market is revising No Change the revenue expectations for PRPO for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 38.73%.
arrow icon

How many employees does Precipio Inc (PRPO). have?

Precipio Inc (PRPO) has 54 emplpoyees as of December 05 2025.

arrow icon

What is Precipio Inc (PRPO) market cap?

Today PRPO has the market capitalization of 43.12M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free